Active Form of Vitamin B12 Can Prevent Neurodegeneration in Parkinson’s Preclinical Models

Active Form of Vitamin B12 Can Prevent Neurodegeneration in Parkinson’s Preclinical Models
An active form of vitamin B12 can reduce the effects of dopamine loss in Parkinson’s disease caused by genetic mutations in the LRRK2 gene, a study suggests. These finding means that this form of vitamin B12 could be used as the basis for developing new therapies for treating Parkinson’s. The study, “Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric ... read more
Source: Parkinson’s News TodayPublished on 2019-04-29By Alice Melão